KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Invested Capital (2017 - 2026)

Twist Bioscience has reported Invested Capital over the past 10 years, most recently at $455.1 million for Q1 2026.

  • Quarterly Invested Capital rose 3.41% to $455.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $455.1 million through Mar 2026, up 3.41% year-over-year, with the annual reading at $473.0 million for FY2025, 0.06% changed from the prior year.
  • Invested Capital was $455.1 million for Q1 2026 at Twist Bioscience, roughly flat from $456.1 million in the prior quarter.
  • Over five years, Invested Capital peaked at $863.4 million in Q1 2022 and troughed at $440.1 million in Q1 2025.
  • The 5-year median for Invested Capital is $560.1 million (2024), against an average of $592.8 million.
  • Year-over-year, Invested Capital soared 39.85% in 2022 and then fell 25.31% in 2024.
  • A 5-year view of Invested Capital shows it stood at $746.3 million in 2022, then fell by 20.94% to $590.0 million in 2023, then decreased by 22.73% to $455.9 million in 2024, then increased by 0.03% to $456.1 million in 2025, then fell by 0.22% to $455.1 million in 2026.
  • Per Business Quant, the three most recent readings for TWST's Invested Capital are $455.1 million (Q1 2026), $456.1 million (Q4 2025), and $473.0 million (Q3 2025).